Natacyn and Eye pain - a phase IV clinical study of FDA data

Summary:

Eye pain is reported as a side effect among people who take Natacyn (natamycin), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Voriconazole, and have Eye infection.

The phase IV clinical study analyzes which people have Eye pain when taking Natacyn. It is created by eHealthMe based on reports of 105 people who have side effects when taking Natacyn from the FDA, and is updated regularly.

What is Natacyn?

Natacyn has active ingredients of natamycin. eHealthMe is studying from 105 Natacyn users. Check the latest studies of Natacyn.

What is Eye pain?

Eye pain is found to be associated with 1,762 drugs and 2,465 conditions by eHealthMe. Check the latest studies of Eye pain.

On Jul, 05, 2026

105 people reported to have side effects when taking Natacyn.
Among them, 29 people (27.62%) have Eye pain.

Among these 29 people:

How long have people been on Natacyn when they have Eye pain? *

What is the gender of people who have Eye pain when taking Natacyn? *

female: 72.41 %
male: 27.59 %

What is the age of people who have Eye pain when taking Natacyn? *

What are other drugs people take besides Natacyn? *

What are other side effects people have besides Eye pain? *

Foreign Body Sensation In Eyes (feeling of something in eye): 10 people, 34.48%
Ocular Hyperaemia (an abnormally large amount of blood in eye): 9 people, 31.03%
Eye Irritation: 8 people, 27.59%
Lacrimation Increased: 5 people, 17.24%
Ocular Discomfort (a generic expression when there is lack of ease in/about the eyes): 5 people, 17.24%
Eye Discharge: 4 people, 13.79%
Foreign Body In Eye (foreign particle in eye): 4 people, 13.79%
Eye Inflammation: 3 people, 10.34%
Eye Pruritus (eye itching): 3 people, 10.34%
Eye Infection Fungal: 3 people, 10.34%

What are the existing conditions these people have? *

Eye Infection: 5 people, 17.24%
Ulcerative Keratitis (ulcerative inflammation of the cornea): 4 people, 13.79%
Eye Infection Fungal: 4 people, 13.79%
Psoriasis (immune-mediated disease that affects the skin): 2 people, 6.90%
Neurotrophic Keratopathy (decreased corneal sensitivity and poor corneal healing): 2 people, 6.90%
Multiple Allergies (allergy to multiple agents): 2 people, 6.90%
Macular Degeneration (painless eye condition that leads to the gradual loss of central vision): 1 person, 3.45%
Injury Corneal: 1 person, 3.45%
Infection: 1 person, 3.45%
Hypoaesthesia Eye (reduced sense of touch or sensation on eyes): 1 person, 3.45%

* Approximation only. Some reports may have incomplete information.

Do you take Natacyn and have Eye pain?

- Check whether Eye pain is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Natacyn:

Natacyn (105 reports)

Eye pain treatments and more:

Eye pain (57,871 reports)

Browse all side effects of Natacyn:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Eye pain:

Eye pain (1,762 drugs)

Browse all the conditions that are associated with Eye pain:

Eye pain (2,465 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on natamycin (the active ingredients of Natacyn) and Natacyn (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.